Intratumoral 224Ra-loaded wires spread alpha-emitters inside solid human tumors in athymic mice achieving tumor control

Tomer Cooks, Michal Tal, Sefi Raab, Margalit Efrati, Shira Reitkopf, Elinor Lazarov, Revital Etzyoni, Michael Schmidt, Lior Arazi, Itzhak Kelson, Yona Keisari

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Background: We developed a new method of brachytherapy, termed diffusing alpha-emitters radiation therapy (DaRT), based on the use of intratumoral 224Ra-loaded wires, which release short-lived alpha-emitting atoms by recoil. Here, we examined their ability to destroy and control the development of several human-derived tumors implanted in athymic mice. Materials and Methods: The experiments were performed on athymic mice bearing malignant human-derived tumors including prostate (PC-3), glioblastoma (GBM, U87-MG), colon (HCT15), squamous cell carcinoma (FaDu) and melanoma (C32). One or more 224Ra-loaded wires were inserted into the tumors, and mice were assessed for tumor growth rate and survival. Results: In vivo studies showed that DaRT can effectively destroy the tumors, and in vitro tests confirmed the sensitivity of the studied cells to alpha particles. While the C32 cells were relatively resistant, other tumor types (e.g. HCT15) exhibited sensitivity in both measured aspects. Conclusion: DaRT could potentially be combined with chemotherapy or other treatment modalities to effectively treat non-resectable tumors.

Original languageEnglish
Pages (from-to)5315-5321
Number of pages7
JournalAnticancer Research
Volume32
Issue number12
StatePublished - 1 Dec 2012
Externally publishedYes

Keywords

  • Alpha radiation
  • Brachytherapy
  • Radiotherapy
  • Solid tumor ablation

Fingerprint

Dive into the research topics of 'Intratumoral <sup>224</sup>Ra-loaded wires spread alpha-emitters inside solid human tumors in athymic mice achieving tumor control'. Together they form a unique fingerprint.

Cite this